Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the ...

Crews searched for bodies Thursday as people tried to salvage what they could following monstrous flash floods in Spain.

Check out royalpurplenews.com and visit local distribution stands for newspapers. News sections include news, opinions, arts ...

Nirmatrelvir-ritonavir effectively lowers hospitalization rates and long COVID symptoms in non-hospitalized, high-risk patients with mild to moderate COVID-19.

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

At the time, Lair was a master painter and plasterer who had been asked to help put up a series of framed photographs ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

By Jack Phillips Contributing Writer Recent estimates published by the U.S. Centers for Disease Control and Prevention show ...

A 14-day course of the oral anti-inflammatory drug montelukast didn't shorten symptom duration in nonhospitalized US adults with mild or moderate COVID-19, finds a randomized controlled clinical trial ...

At the moment, there is no information on how quickly the new vaccine ... and NHS to make Spikevax Bivalent Original/Omicron available to the UK public," said Moderna in a statement.

On NBC 10 News Today, Alpha Omicron PI at the University of Louisiana Monroe just finished their Annual funding for the ...

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...